Aironax Pharmaceuticals Private Limited
About Aironax Pharmaceuticals Private Limited
Data last updated:
Aironax Pharmaceuticals Private Limited is a private limited company based in Vadodara, Gujarat, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 29 March 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24239GJ2019PTC107343. Its GSTIN is 09AASCA1147R1ZX (Uttar Pradesh).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹20,000. It is led by directors including Vivek Shrivastav and Vijay Kumar Srivastava.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at E – 402 The Imperia B.H Yash Complex Gotri Rd Village – Vadodara Taluka, Gujarat, India – 390021.
As per the financials filed for FY 2025, the company reported a revenue of ₹65.15 Lakh, a growth of 138% compared to the previous year. For the same year it recorded a net profit of ₹21,257 (net margin 0.3%) and EBITDA of ₹30,404 (EBITDA margin 0.5%). Revenue has grown at a compounded annual rate (CAGR) of 8% over three years and 45% over five years.
Company details
Contact details
Aironax Pharmaceuticals Private Limited's registered office is in Vadodara, Gujarat. Its e-mail address is in the company report.
- Email
- Registered AddressE – 402 The Imperia B.H Yash Complex Gotri Rd Village – Vadodara Taluka, Gujarat, India – 390021
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Aironax Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Aironax Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Aironax Pharmaceuticals Private Limited, buy the company report.
Financials of Aironax Pharmaceuticals Private Limited
FY 2025 filings availableAironax Pharmaceuticals Private Limited reported revenue of ₹65.15 Lakh (up 138% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 45% over five years, including 138% growth in the latest year. EBITDA rose 2% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹30,404 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹21,257 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.5% | ||||
| Net Profit Margin | 0.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Aironax Pharmaceuticals Private Limited, buy the company report.
Board of directors of Aironax Pharmaceuticals Private Limited
Aironax Pharmaceuticals has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Jaya Rani Sriwastava | Additional Director | 20 Jun 2019 | 7 Years 4 Months | Current |
| Vivek Shrivastav | Director | 29 Mar 2019 | 7 Years 6 Months | Current |
| Vijay Kumar Srivastava Also directs: Uvmax Laboratories Private Limited | Director | 29 Mar 2019 | 7 Years 6 Months | Current |
Peer comparison
Aironax Pharmaceuticals Private Limited is compared with the 8 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Victro Pharmaceuticals Private Limited | ₹65.24 Lakh (FY 2025) | -30.0% | New Delhi, Delhi, India | |||
| Akon Pharmaceuticals Private Limited | ₹65.2 Lakh (FY 2024) | 196.0% | Surat, Gujarat, India | |||
| Zecon Pharmaceuticals Private Limited | ₹65.17 Lakh (FY 2024) | -77.0% | Lucknow, Uttar Pradesh, India | |||
| Aironax Pharmaceuticals Private Limitedthis company | ₹65.15 Lakh (FY 2025) | ₹21,257 | 0.3% | 138.0% | Vadodara, Gujarat, India | |
| Almonds Pharmaceuticals Private Limited | ₹65.07 Lakh (FY 2021) | 5.0% | Kolar, Karnataka, India | |||
| Gopal Pharma Private Limited | ₹65.03 Lakh (FY 2024) | -12.0% | Uttar Pradesh, India | |||
| SMS Meditech India Private Limited | ₹65.03 Lakh (FY 2018) | 188.0% | Ghaziabad, Uttar Pradesh, India | |||
| Grebitor Healthcare Private Limited | ₹64.77 Lakh (FY 2025) | 35.0% | Pune, Maharashtra, India | |||
| Kyriz Pharmaceuticals Private Limited | ₹64.74 Lakh (FY 2024) | Panchkula, Haryana, India |
To see the full peer comparison of Aironax Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Aironax Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Aironax Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Aironax Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AASCA1147R1ZX | Uttar Pradesh | Active | 06 Jul 2019 |
To see the full GST registrations and return filing status of Aironax Pharmaceuticals Private Limited, buy the company report.
Recent activity
Aironax Pharmaceuticals Private Limited has 3 board changes on record since 2019: 3 appointments. The latest: Jaya Rani Sriwastava was appointed as Additional Director on 20 Jun 2019.
Frequently asked questions
Aironax Pharmaceuticals is an active private limited company based in Vadodara, Gujarat, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 29 March 2019 (7+ years old) and is registered under CIN U24239GJ2019PTC107343.
Aironax Pharmaceuticals has 3 current directors:
- Jaya Rani Sriwastava - Additional Director
- Vivek Shrivastav - Director
- Vijay Kumar Srivastava - Director
The latest financial statements of Aironax Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Aironax Pharmaceuticals is 09AASCA1147R1ZX, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Aironax Pharmaceuticals is U24239GJ2019PTC107343. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Aironax Pharmaceuticals was incorporated on 29 March 2019, making it 7+ years old. It is registered with the Registrar of Companies, Ahmedabad.
The peers of Aironax Pharmaceuticals by revenue are Victro Pharmaceuticals Private Limited, Akon Pharmaceuticals Private Limited, Zecon Pharmaceuticals Private Limited, Almonds Pharmaceuticals Private Limited, Gopal Pharma Private Limited and 3 more, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading).
Jaya Rani Sriwastava was appointed as Additional Director on 20 Jun 2019. Vijay Kumar Srivastava was appointed as Director on 29 Mar 2019. Vivek Shrivastav was appointed as Director on 29 Mar 2019.
The registered office of Aironax Pharmaceuticals is at E – 402 The Imperia B.H Yash Complex Gotri Rd Village – Vadodara Taluka, Gujarat, India – 390021.
Aironax Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Aironax Pharmaceuticals can be reached at its registered office: E – 402 The Imperia B.H Yash Complex Gotri Rd Village – Vadodara Taluka, Gujarat, India – 390021.